NCT05597527 2022-10-28
Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Fujian Cancer Hospital
Phase 2 Unknown
Clinical Trials
22 trialsNCT05380986 2022-05-19
Camrelizumab Combined With Apatinib Mesylate
Henan Cancer Hospital
Phase NA Unknown
NCT04901754 2021-12-08
CAMERA
Henan Cancer Hospital
Phase 2 Unknown
NCT04832204 2021-04-05
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Beijing Hospital
Phase 2 Unknown
NCT03389087 2020-07-10
Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT03397199 2020-04-15
Study of Apatinib Plus S-1 as the Therapy of Advanced Colorectal Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT04174339 2019-11-22
PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer
Fujian Cancer Hospital
Phase NA Unknown
NCT03986515 2019-06-14
Apatinib Plus SHR1210 in Advanced Mucosal Melanoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03954756 2019-05-17
Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT03950141 2019-05-15
Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer
Beijing Hospital
Phase 2 Unknown
NCT03942068 2019-05-08
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT02697838 2018-10-17
Clinical Trial of Apatinib Reverses Chemotherapy-Resistance of Patients With Advanced Gastric Cancer
Fujian Cancer Hospital
Phase 2 Unknown
NCT03599778 2018-07-26
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Anhui Provincial Hospital
Phase 1/2 Unknown
NCT03546855 2018-06-06
Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy.
Anhui Provincial Hospital
Phase 2 Unknown
NCT03547375 2018-06-06
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Anhui Provincial Hospital
Phase 2 Unknown
NCT03424291 2018-02-06
A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03383237 2017-12-27
Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma
Henan Cancer Hospital
Phase 2 Unknown
NCT03334591 2017-11-14
Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric Cancer
Anhui Provincial Hospital
Phase 2 Unknown
NCT03170310 2017-05-31
Apatinib Treatment for Advanced Esophagus Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT03163381 2017-05-23
Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.
Henan Cancer Hospital
Phase 2 Unknown
NCT03030937 2017-01-25
Clinical Trial to Compare Apatinib Plus Irinotecan Versus Single Irinotecan as Second-line Treatment in AGC or EGJA
Fujian Cancer Hospital
Phase 2 Unknown
NCT02980809 2016-12-02
Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer
First Hospitals affiliated to the China PLA General Hospital
Phase 2 Unknown